We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+14.34%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$546M
AUM Growth
+$146M
(+36%)
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
17.28%
Top 10 Holdings %
Top 10 Hldgs %
77.86%
Holding
148
New
66
Increased
27
Reduced
14
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGU
Agrium
AGU
|
+$5.04M |
| 2 |
Dover
DOV
|
+$4.81M |
| 3 |
FedEx
FDX
|
+$4.81M |
| 4 |
Celanese
CE
|
+$4.28M |
| 5 |
Bunge Global
BG
|
+$3.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CADE
Cadence Bank
CADE
|
+$2.17M |
| 2 |
Huntington Bancshares
HBAN
|
+$2.12M |
| 3 |
Edwards Lifesciences
EW
|
+$1.82M |
| 4 |
M&T Bank
MTB
|
+$1.72M |
| 5 |
Biogen
BIIB
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 9.04% |
| 2 | Financials | 8% |
| 3 | Healthcare | 4.75% |
| 4 | Materials | 3.56% |
| 5 | Technology | 1.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
PayPal
PYPL
$48.9B
| $353K | 0.06% |
8,200
+2,046
| +33% | +$85.6K |
|
102
FormFactor
FORM
$8.28B
| $331K | 0.06% |
+27,927
| New | +$324K |
|
|
CAMP
103
DELISTED
CalAmp Corp.
CAMP
| $282K | 0.05% |
730
+40
| +6% | +$14.5K |
|
|
LUMO
104
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $263K | 0.05% |
+1,215
| New | +$174K |
|
105
CALL
Honeywell
HON
$77B
| $255K | 0.05% |
+83,025
| New | +$9.17M |
|
106
Nektar Therapeutics
NKTR
$2.39B
| $247K | 0.05% |
+702
| New | +$158K |
|
107
Ciena
CIEN
$53.4B
| $245K | 0.04% |
+10,374
| New | +$254K |
|
108
Chegg
CHGG
$110M
| $234K | 0.04% |
27,769
-22,585
| -45% | -$174K |
|
109
MACOM Technology Solutions
MTSI
$19.2B
| $224K | 0.04% |
+4,647
| New | +$217K |
|
|
CUDA
110
DELISTED
Barracuda Networks, Inc.
CUDA
| $214K | 0.04% |
+9,281
| New | +$217K |
|
|
BSFT
111
DELISTED
BroadSoft, Inc.
BSFT
| $214K | 0.04% |
5,321
-3,718
| -41% | -$158K |
|
|
BNFT
112
DELISTED
Benefitfocus, Inc.
BNFT
| $209K | 0.04% |
7,490
-347
| -4% | -$9.94K |
|
113
Acadia Healthcare
ACHC
$2.76B
| – | – |
-15,557
| Closed | -$515K |
|
114
Adobe
ADBE
$99.5B
| – | – |
-6,573
| Closed | -$677K |
|
115
Agios Pharmaceuticals
AGIO
$1.79B
| – | – |
-7,778
| Closed | -$325K |
|
|
AXDX
116
DELISTED
Accelerate Diagnostics
AXDX
| – | – |
-4,547
| Closed | -$944K |
|
|
117
Biogen
BIIB
$30B
| – | – |
-5,832
| Closed | -$1.65M |
|
|
CADE
118
DELISTED
Cadence Bank
CADE
| – | – |
-70,000
| Closed | -$2.17M |
|
119
Crown Castle
CCI
$33.3B
| – | – |
-5,289
| Closed | -$459K |
|
120
Core Laboratories
CLB
$490M
| – | – |
-4,242
| Closed | -$509K |
|
121
Euronet Worldwide
EEFT
$2.72B
| – | – |
-4,281
| Closed | -$310K |
|
|
122
Edwards Lifesciences
EW
$49.6B
| – | – |
-58,341
| Closed | -$1.82M |
|
123
Eagle Materials
EXP
$6.29B
| – | – |
-3,992
| Closed | -$393K |
|
124
Flotek Industries
FTK
$852M
| – | – |
-3,583
| Closed | -$202K |
|
|
125
Huntington Bancshares
HBAN
$34.4B
| – | – |
-160,000
| Closed | -$2.12M |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q1 2017 Portfolio in Review
As of Q1 2017, Crestline Management held 148 positions worth $546M, up 36% from $401M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Crestline Management deployed $94.4M of net new capital in Q1 2017, opening 66 new positions and adding to 27 existing holdings. Its largest new stake was Agrium: 50,000 shares worth $4.78M.
By sector, the portfolio is most concentrated in Industrials at 9% of assets, up from 2.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $1.25M trimmed.
- Crestline Management's largest Q1 2017 buy was Agrium: 50,000 shares worth $4.78M.
- Crestline Management added most to US Bancorp in Q1 2017, an estimated $2.67M increase.
- Crestline Management's biggest Q1 2017 reduction was Zimmer Biomet, cutting an estimated $1.25M.
- Crestline Management fully exited Cadence Bank in Q1 2017, selling an estimated $2.17M.
- Crestline Management's ten largest holdings make up 78% of its $546M portfolio in Q1 2017.
- Crestline Management opened 66 new positions and closed 36 in Q1 2017.
- Crestline Management's portfolio value rose 36% quarter-over-quarter to $546M.
Based on Crestline Management's 13F filing for Q1 2017, filed 12 May 2017.